Bioactivity | Belrestotug (EOS-448) is an antagonistic anti-TIGIT (VSIG9, VSTM3) human immunoglobulin G1 kappa (hIgG1 kappa) antibody. Belrestotug shows antineoplastic activity[1]. |
Name | Belrestotug |
CAS | 2574438-65-4 |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022. |